| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |